Stem Cell Research (Dec 2024)

Generation of patient-derived induced pluripotent stem cell line UJSi004-A from ultra-treatment-resistant schizophrenia

  • Siyu Xi,
  • Bing Xue,
  • Yupeng Wang,
  • Zhenghua Shan,
  • Tianchi Song,
  • Jing Sun,
  • Shengying Qin

DOI
https://doi.org/10.1016/j.scr.2024.103575
Journal volume & issue
Vol. 81
p. 103575

Abstract

Read online

Schizophrenia is a severe mental illness with disabling effects. Induced pluripotent stem cells (iPSCs) are generated by reprogramming peripheral blood mononuclear cells (PBMCs) from patients with ultra-treatment-resistant schizophrenia (UTRS). iPSCs have normal karyotype, express pluripotency markers and differentiate into three germ layers in vivo. This iPSC cell line carries the genetic information of the patient and is a good model for studying disease mechanisms and developing new therapies.